• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kirby McInerney LLP Reminds Orthofix Medical, Inc. (OFIX) Investors of Class Action Filing and Encourages Investors to Contact the Firm

By: Kirby McInerney LLP via GlobeNewswire
September 09, 2024 at 17:38 PM EDT

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of those who acquired Orthofix Medical, Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX) securities during the period of October 11, 2022 through September 12, 2023, inclusive (“the Class Period”). Investors have until October 21, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[Click here to learn more about the class action]

On September 12, 2023, Orthofix announced the unanimous decision by its Board’s independent directors to terminate and replace the three members of the Company’s management team, after the results of an investigation by independent outside legal counsel led the Board to determine that “each of th[o]se executives engaged in repeated inappropriate and offensive conduct.”  On this news, the price of Orthofix shares declined $5.62 per share, or approximately 30%, from $18.63 on September 11, 2023 to close at $13.01 per share on September 12, 2023.

The Class Action alleges that Orthofix failed to disclose that certain of the Company’s management team had engaged in repeated inappropriate and offensive conduct.

If you purchased or otherwise acquired Orthofix securities, have information, or would like to learn more about this investigation, please contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or by filling out this CONTACT FORM, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-699-1180
https://www.kmllp.com
investigations@kmllp.com


Primary Logo

More News

View More
Why the American Eagle Stock Rally Isn't Just Speculation
Today 17:04 EDT
Via MarketBeat
Topics Government World Trade
Tickers AEO ANF GAP
D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
Today 16:29 EDT
Via MarketBeat
Tickers QBTS
4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
Today 16:11 EDT
Via MarketBeat
Tickers BAC DHI SCHW TDY
3 Reasons Tesla's Post-Earnings Hangover Looks Like a Buy
Today 14:39 EDT
Via MarketBeat
Tickers TSLA
Taiwan Semiconductor Could Boom on This AI Action Plan
Today 13:02 EDT
Via MarketBeat
Topics Artificial Intelligence Government
Tickers NVDA TSM
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap